About Bioaltus
Bioaltus is a Healthcare company based in Mumbai (India) founded in 2014. It provides contract manufacturing and pharmaceutical products for medical fields like diabetology and cardiology. It operates on a B2B and Contract Manufacturing model. The company has 33 employees. Its Indian entity Bioaltus Pharmaceuticals Private Limited reported revenue of ₹118 Cr. Bioaltus offers products and services including Contract Manufacturing, iMickro Technology, Diabetology Products, and Cardiology Products. Its focus areas include Pharmaceuticals, Drug Manufacturing, Contract Production and Therapeutics. Its competitors include Crown Laboratories, Famar, Encube Ethicals, Curida and Formulated Solutions and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
Bioaltus Pharmaceuticals Pvt. Ltd. focuses on developing efficient pharmaceutical formulations using technologies like iMickro Nano. They offer contract manufacturing, institutional services, and international business, serving sectors such as diabetology, cardiology, and nephrology. Based in Mumbai, India, with factories in Baddi and Valsad, they partner with healthcare institutions to provide affordable, high-quality medications and formulations.
- Headquarters Mumbai, India
- Employees 33
- SectorsHealthcare
- Email••••••••
- Website bioaltus.com
- Social LinkedIn Instagram
- Legal Name Bioaltus Pharmaceuticals Private Limited
- Date of Incorporation 21 Mar, 2014
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹118 Cr
FY 2025 · +26% YoY
- Net Profit₹10.21 Cr
FY 2025 · 9% margin
- EBITDA₹14.78 Cr
FY 2025 · 13% margin
- Employee Count33
Associated legal entities of Bioaltus
Bioaltus operates through Bioaltus Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bioaltus Pharmaceuticals Private Limited CIN U74900MH2014PTC254786 | Active | 21 Mar 2014 | Thane, Maharashtra | ₹118 Cr | 33 | 2 | View details |
Products & Services of Bioaltus
Bioaltus offers a comprehensive portfolio of products and services, including Contract Manufacturing, iMickro Technology, Diabetology Products, and Cardiology Products.
Third-party production of pharmaceutical formulations for partners
Advanced system for efficient and potent drug formulations
Formulations for diabetes management and treatment
Medications for heart-related conditions and care
Board of directors of Bioaltus Pharmaceuticals Private Limited (Bioaltus)
Bioaltus Pharmaceuticals Private Limited is the primary company behind Bioaltus. The board of Bioaltus Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Ankit Varshney, appointed in 2014. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ankit Varshney DIN 06836404 | Whole-time director | 21 Mar 2014 | 12 yrs 7 mo | Bioaltus Pharmaceuticals Private Limited |
| Gopinath Ramankutty Nair DIN 06460154 | Whole-time director | 18 Aug 2014 | 12 yrs 2 mo | Bioaltus Pharmaceuticals Private Limited |
Financials of Bioaltus
Figures of Bioaltus Pharmaceuticals Private Limited, the primary company behind Bioaltus, for FY 2025. Revenue was ₹118 Cr (+26% year on year). Net profit was ₹10.21 Cr (9% margin). EBITDA was ₹14.78 Cr (13% margin). Revenue has grown at a compounded annual rate of +14% over three years and +17% over five years.
- ₹118 CrRevenue · FY 2025 · +26% YoY
- ₹10.21 CrNet profit · 9% margin
- ₹14.78 CrEBITDA · 13% margin
- ₹92.9 LakhPaid-up capital
- 33Employees (provident fund records)
- +14%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bioaltus Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Bioaltus
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Bioaltus
Bioaltus has 8 listed competitors in our database, 2 of them funded. They include Crown Laboratories, Famar, Encube Ethicals, Curida and Formulated Solutions, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| crownlaboratories.com | 2000 | Johnson, United States | – | – | OTC, prescription, skin care, and oral care products are manufactured. | |
| famar-group.com | 1949 | Athens, Greece | – | – | Contract manufacturing and development services provider | |
| encubeethicals.com | 1998 | Mumbai, India | $65.53M | 1,447 | Contract development and manufacturing for topical semisolid formulations are provided. | |
| curida.no | 2015 | Elverum, Norway | $3.2M | 65 | Liquid pharmaceuticals are developed via blow fill seal technology. | |
| formulatedsolutions.com | 1999 | Largo, United States | – | 407 | Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors | |
| cplltd.com | 1991 | Mississauga, Canada | – | – | CDMO focused on manufacturing of semi-solid pharmaceutical drugs | |
| chemineau.com | 1947 | Vouvray, France | – | – | CDMO specializing in ENT and topical dosage forms | |
| pharmasol.com | 1996 | Easton, United States | – | – | Pharmasol is recognized as a Contract Development and Manufacturing Organization. |
Detailed competitors of Bioaltus
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bioaltus
The website of Bioaltus (bioaltus.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 16.7% vs previous month
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Bioaltus (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bioaltus
Bioaltus was founded in 2014.
Bioaltus is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Bioaltus has 33 employees.
The primary company behind Bioaltus, Bioaltus Pharmaceuticals Private Limited, reported revenue of ₹118 Cr for FY 2025, up 26% year on year.
Bioaltus Pharmaceuticals Pvt. Ltd. focuses on developing efficient pharmaceutical formulations using technologies like iMickro Nano. They offer contract manufacturing, institutional services, and international business, serving sectors such as diabetology, cardiology, and nephrology. Based in Mumbai, India, with factories in Baddi and Valsad, they partner with healthcare institutions to provide affordable, high-quality medications and formulations.
Bioaltus's top competitors include Encube Ethicals, Famar and Crown Laboratories.
Bioaltus offers Contract Manufacturing, iMickro Technology, Diabetology Products, and Cardiology Products.
Bioaltus operates through Bioaltus Pharmaceuticals Private Limited.
The legal entities of Bioaltus currently have 2 directors, including Ankit Varshney, Gopinath Ramankutty Nair.